| 1 |
34615727 | Novel therapeutic targets for cholestatic and fatty liver disease. | 2022 Jan |
2 |
| 2 |
35066087 | Is it time for chronopharmacology in NASH? | 2022 May |
2 |
| 3 |
33318189 | FXR mediates T cell-intrinsic responses to reduced feeding during infection. | 2020 Dec 29 |
1 |
| 4 |
26824277 | SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound. | 2016 |
1 |
| 5 |
25869321 | A novel formulation of veggies with potent liver detoxifying activity. | 2015 |
2 |
| 6 |
20373033 | Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase. | 2011 Jan |
1 |
| 7 |
20444884 | Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner. | 2010 Jul |
1 |
| 8 |
15721319 | Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor. | 2005 Apr 1 |
1 |